Neurodegenerative Diseases

• EMA approval · 2022-05-24
  EMA Authorised: Amifampridine SERB (amifampridine phosphate) — SERB SA

  European Medicines Agency authorises amifampridine phosphate (SERB) for various neuromuscular and autoimmune conditions, with Lambert-Eaton …

• FDA approval · 2015-07-17
  FDA Approved: FLUDEOXYGLUCOSE F18 — Original Application (The Regents of the University of Michigan)

  The FDA approved the Original Application for Fludeoxyglucose F-18, a radiopharmaceutical used for PET imaging. The submission was sponsored…

• FDA approval · 2012-11-28
  FDA Approved: FLUDEOXYGLUCOSE F18 — Supplemental Application (THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH)

  FDA has approved a supplemental application for Fludeoxyglucose F-18, a PET radiopharmaceutical, reflecting an update to its labeling and/or…